| CIS | carcinoma in situ |
| aOR | adjusted odds ratio |
| ASC-H | atypical squamous cells-cannot exclude HSIL |
| ASC-US | atypical squamous cells of undetermined significance |
| ASCCP | American Society for Colposcopy and Cervical Pathology |
| CI | confidence interval |
| CIN | cervical intraepithelial neoplasia |
| CIN2+ | cervical intraepithelial neoplasia grade 2 or worse (CIN2, CIN3, or carcinoma in situ) |
| CIN3+ | cervical intraepithelial neoplasia grade 3 or worse (CIN3 or carcinoma in situ) |
| ECC | endocervical curettage |
| EU | European Union |
| GDPR | General Data Protection Regulation |
| GLOBOCAN | Global Cancer Observatory cancer incidence and mortality database |
| HPV | human papillomavirus |
| hrHPV | high-risk human papillomavirus |
| HSIL | high-grade squamous intraepithelial lesion |
| LSIL | low-grade squamous intraepithelial lesion |
| NILM | negative for intraepithelial lesion or malignancy |
| R | R statistical computing environment |
| SCJ | squamocolumnar junction |
| SD | standard deviation |
| SPSS | Statistical Package for the Social Sciences |
| STROBE | Strengthening the Reporting of Observational Studies in Epidemiology |
| TZ | transformation zone |
| TZ3 | type 3 transformation zone |
| WHO | World Health Organization |